FOR IMMEDIATE RELEASE
MESA, Ariz. — December 18, 2025
We’re thrilled to announce that our latest systematic review is now officially published and freely available online today! Titled “Comparison of the Surgical Treatment of Adnexal Masses in Pediatric and Adolescent Patients by Gynecologic Surgeons versus Pediatric Surgeons, a Systematic Review”, this work—led by Greg J. Marchand and colleagues from the Marchand Institute for Minimally Invasive Surgery—provides important insights into optimizing care for young patients with ovarian and adnexal lesions.
The review highlights key advantages when gynecologic surgeons lead these procedures, including significantly lower complication rates, higher rates of ovarian-sparing surgery, fewer conversions from laparoscopy to open surgery, shorter hospital stays, and reduced risk of tumor spillage—while maintaining similar recurrence rates compared to pediatric surgeons. These findings underscore the value of specialized gynecologic expertise in pediatric and adolescent cases, and we believe this work will help guide clinical decision-making and improve outcomes for young patients.
Best of all, the full paper is open access and completely free to read right now. Here are the direct links:
- PubMed (abstract and full-text links): https://pubmed.ncbi.nlm.nih.gov/41409751/
- Free full-text on PubMed Central: https://pmc.ncbi.nlm.nih.gov/articles/PMC12706157/
- Publisher’s site (Dove Press / International Journal of Women’s Health): https://doi.org/10.2147/ijwh.s544674
We invite clinicians, researchers, and anyone interested in pediatric gynecology to dive in and share this important contribution. Thank you for your continued support—excited to see the impact this research will have!
About the Marchand Institute for Minimally Invasive Surgery
The Marchand Institute for Minimally Invasive Surgery is a 501(c)(3) tax-exempt non-profit research and educational institution based in Mesa, Arizona (EIN 42-2857240). The Institute produces peer-reviewed systematic reviews and meta-analyses in minimally invasive gynecologic surgery and women’s health, conducts FDA clinical trials, and trains surgeons through an SLS-accredited fellowship. All reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised using the Cochrane RoB 2 tool. The Institute accepts no pharmaceutical or medical device industry funding and declares no conflicts of interest. It is directed by Greg J. Marchand, MD, FACS, FACOG, FICS.
Media Contact
Maria A. Sainz, Director of Communications and Media Relations
Marchand Institute for Minimally Invasive Surgery
maria@marchandobgyn.com | (480) 999-0905
Interview requests, expert commentary topics, boilerplate and high-resolution images: Newsroom & Press Kit. Complete publication record with DOIs and PMIDs: Publications database. Methodology: How we run a review.
###